[go: up one dir, main page]

WO2000041670A3 - Pharmaceutical forms and methods for penetration continuity - Google Patents

Pharmaceutical forms and methods for penetration continuity Download PDF

Info

Publication number
WO2000041670A3
WO2000041670A3 PCT/TR2000/000001 TR0000001W WO0041670A3 WO 2000041670 A3 WO2000041670 A3 WO 2000041670A3 TR 0000001 W TR0000001 W TR 0000001W WO 0041670 A3 WO0041670 A3 WO 0041670A3
Authority
WO
WIPO (PCT)
Prior art keywords
soft
stick
methods
penetration
pharmaceutical forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2000/000001
Other languages
French (fr)
Other versions
WO2000041670A2 (en
Inventor
Ahmet Degirmenci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU38538/00A priority Critical patent/AU3853800A/en
Publication of WO2000041670A2 publication Critical patent/WO2000041670A2/en
Anticipated expiration legal-status Critical
Publication of WO2000041670A3 publication Critical patent/WO2000041670A3/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Since topical medicaments having fluidity such as ointment, dressing are removed within a short time as a result of excessive motility and friction of their site of application such as lips, joints and similar parts, penetration of antiviral material into skin and therefore, topical treatment is most of the time hindered. The present invention is concerned with forms and methods to ensure penetration continuity that use soft stick, soft remedial stick, soft pencil, thermic soft stick, soft stick containing Acyclovir, supportive Herpes Labialis plaster that help treatment.
PCT/TR2000/000001 1999-01-11 2000-01-11 Pharmaceutical forms and methods for penetration continuity Ceased WO2000041670A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU38538/00A AU3853800A (en) 1999-01-11 2000-01-11 Pharmaceutical forms and methods for penetration continuity

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
TR99/00033 1999-01-11
TR9900033 1999-01-11
TR9903291 1999-12-28
TR99/03291 1999-12-28

Publications (2)

Publication Number Publication Date
WO2000041670A2 WO2000041670A2 (en) 2000-07-20
WO2000041670A3 true WO2000041670A3 (en) 2008-02-14

Family

ID=26666345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2000/000001 Ceased WO2000041670A2 (en) 1999-01-11 2000-01-11 Pharmaceutical forms and methods for penetration continuity

Country Status (2)

Country Link
AU (1) AU3853800A (en)
WO (1) WO2000041670A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051259A2 (en) 2003-11-28 2005-06-09 Coloplast A/S A dressing product
WO2006024284A2 (en) 2004-09-01 2006-03-09 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Atrium patch
DE102005050654A1 (en) * 2005-10-20 2007-04-26 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH lip paving

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615633A (en) * 1983-11-09 1986-10-07 Societe Anonyme Dite: L'oreal Pharmaceutical or cosmetic composition in the form of a rod or stick constituted from two concentric fatty phases and a casting permitting its preservation and distribution
WO1998018472A1 (en) * 1996-10-31 1998-05-07 Recordati S.A. Chemical And Pharmaceutical Company Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615633A (en) * 1983-11-09 1986-10-07 Societe Anonyme Dite: L'oreal Pharmaceutical or cosmetic composition in the form of a rod or stick constituted from two concentric fatty phases and a casting permitting its preservation and distribution
WO1998018472A1 (en) * 1996-10-31 1998-05-07 Recordati S.A. Chemical And Pharmaceutical Company Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators

Also Published As

Publication number Publication date
AU3853800A (en) 2000-08-01
WO2000041670A2 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
AU4756085A (en) Purine derivatives and use as therapeutic agent
PT2450043T (en) Pharmaceutical composition for dermal use to treat psoriasis comprising calcipotriol and betamethasone
NO991910D0 (en) Antiherpes pharmaceutical composition containing acyclovir for topical applicators
IT8024370A0 (en) THERAPEUTIC COMPOSITION OF DIMETHYL SULPHOXIDE AND PROCEDURES FOR ITS USE.
PT90197A (en) Process for the preparation of a moisturizing anti-inflammatory composition for the skin
PT90198A (en) Process for the preparation of a moisturizing anti-inflammatory composition for the skin
AU2003209285A1 (en) Deazapurine nucleoside analogs and their use as therapeutic agents
MX160316A (en) PROCEDURE TO PREPARE A THERAPEUTIC COMPOSITION OF PROLONGED ACTION BASED ON HYDROXYPROPYLMETILCELLULOSE
CY1112753T1 (en) HUMAN BODY CANCER TREATMENT BY USE TO743
EP0017937A3 (en) Bonding compositions to the hard tissue of human body
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
DK64988A (en) SURGICAL TOOLS TO STRETCH THE SKIN
IT1184922B (en) APPARATUS FOR THE CONTROLLED APPLICATION ON HUMAN TISSUE OF REDUCING SUBSTANCES TO REALIZE MICROABRASIONS
ES535711A0 (en) PROCEDURE TO PREPARE A COMPOSITION FOR THE TOPICAL TREATMENT OF ACNE
FI990171A0 (en) Novel compounds and compositions for the treatment of diseases related to tryptase activity
CO5160321A1 (en) NEW COMPOSITIONS OF TIPRANAVIR AND RITONAVIR
PL332430A1 (en) Skin care compositions containing combinations of compounds capable to simulate the action of retinic acid onto skin
FI883352A7 (en) Use of double-stranded RNA to produce a drug for the treatment of inflammation
IT1221826B (en) PREPARED FOR TOPICAL USE FOR THE THERAPEUTIC TREATMENT OF IMPOTENTIA COEUNDI
IT1062422B (en) FINISHING COMPOSITIONS OF ADHESIVE JOINTS AND PROCEDURES TO USE THEM
NO20002487D0 (en) Preparation with azelaic acid
ES287730Y (en) A SET OF APPLICATOR TIP FOR USE IN AN INSTRUMENT SIMILAR TO A PEN
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
WO2000041670A3 (en) Pharmaceutical forms and methods for penetration continuity
DK599986A (en) THERAPEUTIC AGENT IN THE FORM OF A SKIN PLASTER

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase